NHS Finds 6x More Undiagnosed & Miscoded Patients, Halving Treatment Costs 
Venue: Business Design Centre, London, UK
Panel Session: Crafting Personalised Care with AI and Data
Learn how NHS clinicians applied Pangaea’s product to find and connect to 6x more undiagnosed and miscoded cachectic cancer patients compared to generic natural language processing (NLP) and ICD approaches. This led to a 50% reduction in treatment costs from £10,000 to £5,000 per patient, resulting in annual savings of £1B for the NHS in the context of 200,000 such patients in the UK, coupled with improved resource allocation and patient outcomes.
Furthermore, the discovery of these patients benefited the pharmaceutical sponsors by providing an expanded pool of suitable patients for their commercial therapies and trials, fostering sustainable collaboration between the healthcare and pharmaceutical industries to boost efficiency and improve patient outcomes.
Register to Meet Us
Presenter
